SCHEMBL22035957

SCHEMBL22035957

Cc1ccc(C(CC(C(=O)O)c2ccc(C)cc2)C(=O)O)cc1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.51
ALDH1A1 P00352 3/20 0.46
GAA P10253 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
PTGS1 P23219 1/20 0.44
PTGS2 P35354 1/20 0.44
ACHE P22303 1/20 0.44
AKR1C3 P42330 2/20 0.44
AKR1C2 P52895 2/20 0.44
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CNR1 P21554 1/20 0.42
CNR2 P34972 1/20 0.42
LMNA P02545 1/20 0.42
CYP2C19 P33261 1/20 0.41
FFAR1 O14842 1/20 0.41
CPN1 P15169 1/20 0.41
CPB2 Q96IY4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6998990 0.90 POLB (0.51) POLBSMN1; SMN2ALDH1A1GAAL3MBTL1
SCHEMBL31109131 0.90 POLB (0.51) POLBSMN1; SMN2ALDH1A1GAAL3MBTL1
SCHEMBL25248841 0.85 POLB (0.54) POLBSMN1; SMN2ALDH1A1GAAL3MBTL1
SCHEMBL7705115 0.85 ALDH1A1 (0.56) POLBSMN1; SMN2ALDH1A1GAAL3MBTL1
SCHEMBL510548 0.85 ALDH1A1 (0.56) POLBSMN1; SMN2ALDH1A1GAAL3MBTL1
SCHEMBL2276811 0.83 L3MBTL1 (0.66) POLBSMN1; SMN2ALDH1A1GAAL3MBTL1
SCHEMBL9068550 0.83 POLB (0.57) POLBSMN1; SMN2ALDH1A1GAAL3MBTL1
SCHEMBL27897005 0.83 POLB (0.53) POLBSMN1; SMN2ALDH1A1GAAL3MBTL1
SCHEMBL31109105 0.83 POLB (0.61) POLBSMN1; SMN2ALDH1A1GAAL3MBTL1
SCHEMBL9068549 0.83 POLB (0.57) POLBSMN1; SMN2ALDH1A1GAAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115896821-B Electrically promoted CO2Method for synthesizing diacid compound by participating in ring-opening and dicarboxylating reaction of small ring compound 四川大学 2024-06-11 CN disclosed
CN-115896821-A Electrically promoting CO 2 Method for synthesizing diacid compound by participating in ring-opening double-carboxylation reaction of small ring compound 四川大学 2023-04-04 CN disclosed
US-20200165189-A1 PSEUDO TRÖGER'S BASE AMINES AND MICROPOROUS POLYMERS DERIVED FROM PSEUDO TRÖGER'S BASE AMINES UNIV KING ABDULLAH SCI & TECH (SA) 2020-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200165189-A1 PSEUDO TRÖGER'S BASE AMINES AND MICROPOROUS POLYMERS DERIVED FROM PSEUDO TRÖGER'S BASE AMINES PARG, PARN, TPR POLB 629/4885SMN1; SMN2 2159/4885ALDH1A1 4447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.